Deere Share Price Gains 13% YTD: Buy, Sell or Hold the Stock?

Deere & Company (DE) reported a significant downturn in Q3 FY25, with sales falling 8.6% and EPS declining 24% year-over-year, attributed to sustained weak demand across its agricultural and construction segments. Consequently, the company lowered its fiscal 2025 net income outlook to $4.75-$5.25 billion, a substantial reduction from the prior year's $7.1 billion, citing ongoing market challenges and a $600 million tariff impact. Despite the stock's 12.8% year-to-date outperformance against broader indices, analysts have reduced estimates, and the shares trade at a premium valuation (23.33x forward P/E), leading to a Zacks #4 (Sell) recommendation due to near-term headwinds and overvaluation.

Analysis

Deere & Company (DE) presents a significant disconnect between its year-to-date stock performance and its deteriorating business fundamentals. While the stock has gained 12.8%, outpacing the S&P 500 and its industry, the company's financial results reveal considerable weakness. Q3 fiscal 2025 earnings per share plunged 24% year-over-year, and net sales declined 8.6%, marking the seventh consecutive quarter of falling earnings amid sluggish demand. This industry-wide slump, also impacting peers CNH and AGCO, is driven by low commodity prices and tariff uncertainty, which has muted farmer spending. In response, Deere has cut its fiscal 2025 net income guidance for the second time to a range of $4.75-$5.25 billion, substantially below the $7.1 billion reported in fiscal 2024. This guidance anticipates sales declines of 10-20% across its major segments. Despite this negative outlook and downward revisions from analysts, the stock trades at a forward P/E of 23.33x, a premium to both its industry average and its own five-year median of 15.83x. While long-term drivers like precision agriculture and global food demand remain intact, the near-term outlook is challenged by weak fundamentals and a stretched valuation.

Key Decisions for Investors

• Investors should be cautious of the stock's 12.8% year-to-date outperformance, which appears disconnected from the sharp 24% decline in Q3 earnings and the severely reduced fiscal 2025 net income guidance.
• Given the premium forward P/E of 23.33x, which is above historical and industry averages, there is a risk of a valuation correction if headwinds from low commodity prices and weak demand persist.
• Consider waiting for a more attractive entry point or clear signs of a demand recovery before initiating new positions, as consensus estimates do not project a meaningful earnings rebound until fiscal 2026.